Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade glioma.
Park DY, Tom MC, Wei W, Tewari S, Ahluwalia MS, Yu JS, Chao ST, Suh JH, Peereboom D, Stevens GHJ, Barnett GH, Angelov L, Mohammadi AM, Hogan T, Kissel C, Lapin B, Schuermeyer I, Parsons MW, Naugle R, Murphy ES.
Park DY, et al. Among authors: murphy es.
J Neurooncol. 2022 Feb;156(3):499-507. doi: 10.1007/s11060-021-03920-6. Epub 2022 Jan 22.
J Neurooncol. 2022.
PMID: 35064450